FILING ANALYSIS · WEDNESDAY, OCTOBER 28
CONMED Corp CNMD — 8-K: Results of Operations and Financial Condition
neutral
CONMED Corp reported third quarter 2026 financial results with organic constant currency net sales growth of 6.7%, exceeding expectations, and updated its full year 2026 guidance, but adjusted diluted EPS was down 3.2% year-over-year.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →